Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors ...

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

Short interest in 10x Genomics Inc (NASDAQ:TXG) increased during the last reporting period, rising from 12.06M to 12.86M. This put 17.73% of the company's publicly available shares short.

Here are three reasons why there are better opportunities than TXG and a stock we'd rather ... isn't a prominently featured metric in company financials and earnings releases, but we think it's ...

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management ...

Raymond James Financial Inc. acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) during the 4th quarter, Holdings Channel.com reports.The fund acquired 30,005 ...

Nasdaq announced plans to expand its presence in Texas, establishing a new headquarters in Dallas to foster engagement with local financial entities. Meanwhile, the Nasdaq index experienced an 11% ...

PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will ...